Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immunomedics

Executive Summary

Cancer imaging and therapy products being jointly developed with Ortho will revert to Immunomedics under an agreement announced Nov. 21. The J&J subsidiary explained that it had decided to discontinue both internal and external activities in the area of radiolabeled monoclonal antibody projects for cancer imaging and therapy, including support for three products by Immunomedics. Ortho funding will continue until March 31 ("The Pink Sheet" Nov. 14, T&G-8)....
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel